These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 21362794)

  • 41. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type.
    Quartier P; Taupin P; Bourdeaut F; Lemelle I; Pillet P; Bost M; Sibilia J; Koné-Paut I; Gandon-Laloum S; LeBideau M; Bader-Meunier B; Mouy R; Debré M; Landais P; Prieur AM
    Arthritis Rheum; 2003 Apr; 48(4):1093-101. PubMed ID: 12687553
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pulmonary rheumatoid nodules in an etanercept-treated patient.
    Hübscher O; Re R; Iotti R
    Arthritis Rheum; 2003 Jul; 48(7):2077-8. PubMed ID: 12847707
    [No Abstract]   [Full Text] [Related]  

  • 43. Henoch-Schönlein purpura in a patient with rheumatoid arthritis receiving etanercept.
    Asahina A; Ohshima N; Nakayama H; Shirai A; Juji T; Matsui T
    Eur J Dermatol; 2010; 20(4):521-2. PubMed ID: 20413370
    [No Abstract]   [Full Text] [Related]  

  • 44. Is there a link between the use of etanercept and Henoch-Schönlein purpura? Comment on: Henoch-Schonlein purpura in a patient with the rheumatoid arthritis receiving etanercept (Eur J Dermatol 2010; 20: 521-2).
    Park SJ; Kim JH; Shin JI
    Eur J Dermatol; 2011; 21(1):147. PubMed ID: 21227894
    [No Abstract]   [Full Text] [Related]  

  • 45. Coexistent sickle cell disease and juvenile rheumatoid arthritis: 2 cases with delayed diagnosis and severe destructive arthropathy.
    Eberhard BA
    J Rheumatol; 2002 Aug; 29(8):1802; author reply 1802-3. PubMed ID: 12180751
    [No Abstract]   [Full Text] [Related]  

  • 46. Development of diabetes mellitus during etanercept therapy in a child with systemic-onset juvenile rheumatoid arthritis.
    Bloom BJ
    Arthritis Rheum; 2000 Nov; 43(11):2606-8. PubMed ID: 11083287
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Etanercept in the treatment of adult patients with Still's disease.
    Husni ME; Maier AL; Mease PJ; Overman SS; Fraser P; Gravallese EM; Weinblatt ME
    Arthritis Rheum; 2002 May; 46(5):1171-6. PubMed ID: 12115220
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Demyelinating disease and cutaneous lymphocitic vasculitis after etanercept therapy in a patient with rheumatoid arthritis.
    Clemente RE
    Scand J Rheumatol; 2007; 36(3):244-5; author reply 245. PubMed ID: 17657687
    [No Abstract]   [Full Text] [Related]  

  • 49. Fatal streptococcal toxic shock syndrome in a patient with rheumatoid arthritis treated with etanercept.
    Uthman I; Husari A; Touma Z; Kanj SS
    Rheumatology (Oxford); 2005 Sep; 44(9):1200-1. PubMed ID: 15870144
    [No Abstract]   [Full Text] [Related]  

  • 50. Demyelinating disease and cutaneous lymphocitic vasculitis after etanercept therapy in a patient with rheumatoid arthritis.
    Martínez-Taboada VM; Val-Bernal JF; Pesquera LC; Fernández-Llanio NE; Esteban JM; Blanco R; Alonso-Bartolome P; Gonzalez-Vela C; Rodríguez-Valverde V
    Scand J Rheumatol; 2006; 35(4):322-3. PubMed ID: 16882599
    [No Abstract]   [Full Text] [Related]  

  • 51. Management of accelerated pulmonary nodulosis following etanercept therapy in a patient with rheumatoid arthritis.
    Watson P; Simler N; Screaton N; Lillicrap M
    Rheumatology (Oxford); 2008 Jun; 47(6):928-9. PubMed ID: 18385217
    [No Abstract]   [Full Text] [Related]  

  • 52. Safety and efficacy of once weekly etanercept 0.8 mg/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritis.
    Horneff G; Ebert A; Fitter S; Minden K; Foeldvari I; Kümmerle-Deschner J; Thon A; Girschick HJ; Weller F; Huppertz HI
    Rheumatology (Oxford); 2009 Aug; 48(8):916-9. PubMed ID: 19483091
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept.
    Kekow J; Welte T; Kellner U; Pap T
    Arthritis Rheum; 2002 Mar; 46(3):843-4. PubMed ID: 11920425
    [No Abstract]   [Full Text] [Related]  

  • 54. Angio-oedema in a patient treated with etanercept for rheumatoid arthritis.
    Sendur OF; Turan Y; Berkit IK; Tastaban E
    Basic Clin Pharmacol Toxicol; 2009 Jun; 104(6):488-90. PubMed ID: 19371261
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Etanercept induced hidradenitis suppurativa.
    Pellegrino M; Taddeucci P; Peccianti C; Mei S; Fioravanti A; Fimiani M
    G Ital Dermatol Venereol; 2011 Dec; 146(6):503-4. PubMed ID: 22095184
    [No Abstract]   [Full Text] [Related]  

  • 56. Monoarticular septic arthritis in a patient with juvenile rheumatoid arthritis under etanercept treatment.
    Lin KC; Liang CD; Yang KD; Yu HR; Kuo HC
    Rheumatol Int; 2012 May; 32(5):1383-5. PubMed ID: 20349235
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monitoring the long-term safety of therapies for children with juvenile idiopathic arthritis: time for a consolidated patient registry.
    Smith MY; Sobel RE; Wallace CA
    Arthritis Care Res (Hoboken); 2010 Jun; 62(6):800-4. PubMed ID: 20535790
    [No Abstract]   [Full Text] [Related]  

  • 58. Rice bodies in juvenile idiopathic arthritis: a clinical image.
    Cox A; Allen R; Akikusa J
    J Paediatr Child Health; 2012 Mar; 48(3):280. PubMed ID: 22417465
    [No Abstract]   [Full Text] [Related]  

  • 59. Successful treatment in a child with enthesitis-related arthritis involving the sternoclavicular joint: a case report.
    Huang PY; Chang LS; Guo MM; Kuo HC
    BMC Pediatr; 2019 Oct; 19(1):373. PubMed ID: 31647009
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypersensitive joint reaction after etanercept treatment in a patient with juvenile rheumatoid arthritis.
    Guo MM; Yang KD; Yu HR; Kuo HC
    J Rheumatol; 2011 Mar; 38(3):577-9. PubMed ID: 21362794
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.